Mature Pseudomonas aeruginosa biofilms prevail compared to young biofilms in the presence of ceftazidime

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 9, 2012, Pages 4976-4979

  Bowler, Laura L ^a,b   Zhanel, George G ^b   Ball, T Blake ^b,c   Saward, Laura L ^a,b  

^a Cangene Corporation   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; MEROPENEM;

ARTICLE; BACTERIAL GROWTH; BIOFILM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PLANKTON; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SUPERNATANT;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BIOFILMS; CEFTAZIDIME; CIPROFLOXACIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE EXPRESSION; GENTAMICINS; MICROBIAL SENSITIVITY TESTS; PLANKTON; PSEUDOMONAS AERUGINOSA; THIENAMYCINS; TIME FACTORS;

EID: 84865408551     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00650-12     Document Type: Article

References (15)

1. Bagge N, et al. 2004. Dynamics and spatial distribution of β-lactamase expression in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 48:1168-1174. doi:10.1128/AAC.48.4.1168-1174.2004. (Pubitemid 38405470)
2. Bagge N, et al. 2004. Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and β-lactamase and alginate production. Antimicrob. Agents Chemother. 48:1175-1187. doi:10.1128/AAC.48.4. 1175-1187.2004. (Pubitemid 38405471)
3. Baquero F, Vicente MF, Perez-Diaz JC. 1985. β-Lactam coselection of sensitive and TEM-1 β-lactamase-producing subpopulations in heterogeneous Escherichia coli colonies. J. Antimicrob. Chemother. 15:151-157. (Pubitemid 15109079)
4. Ceri H, Olson ME, Stremick C, Read RR, Morck D. 1999. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities. J. Clin. Microbiol. 37:1771-1776. (Pubitemid 29235221)
5. De Kievit TR, et al. 2001. Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 45:1761-1770. doi:10.1128/AAC.45.6.1761-1770.2001. (Pubitemid 32466346)
6. Galarneau A, Primeau M, Trudeau LE, Michnick SW. 2002. β-Lactamase protein fragment complementation assays as in vivo and in vitro sensors of protein-protein interactions. Nat. Biotech. 20:619-622. doi:10.1038/nbt0602-619. (Pubitemid 34595158)
7. Gold R. 1987. Randomized trial of ceftazidime versus placebo in the management of acute respiratory exacerbations in patients with cystic fibrosis. J. Pediatr. 111:907-913. doi:10.1016/S0022-3476(87)80217-2. (Pubitemid 18019173)
8. Griffith DP, Klein AS. 1983. Infection-induced urinary stones, p 210-227. In Roth RA, Finlayson B (ed), Stones: clinical management of urolithiasis. Lippincott, Williams & Wilkins, New York, NY.
9. Mah TF, et al. 2003. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 426:306-310. doi:10.1038/nature02122.
10. Marrie TJ, Nelligan J, Costerton JW. 1982. A scanning and transmission electron microscopic study of an infected endocardial pacemaker lead. Circulation 66:1339-1341. doi:10.1161/01.CIR.66.6.1339. (Pubitemid 13238856)
11. Masuda N, Ohya S. 1992. Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 36:1847-1851. doi:10.1128/AAC.36.9.1847.
12. Nouda H, Harabe ET, Sumita Y, Okuda T, Fukasawa M. 1992. β-Lactamase stability and inhibitory activity of meropenem combined with a potent antibacterial activity. Chemotherapy 38:218-224. doi:10.1159/000239004.
13. Stewart PS, Costerton JW. 2001. Antibiotic resistance of bacteria in biofilms. Lancet 358:135-138. doi:10.1016/S0140-6736(01)05321-1. (Pubitemid 32709857)
14. VanDevanter DR, Van Dalfsen JM. 2005. How much do Pseudomonas biofilms contribute to symptoms of pulmonary exacerbation in cystic fibrosis? Pediatr. Pulmonol. 39:504-506. doi:10.1002/ppul.20220. (Pubitemid 40696320)
15. Wu PJ, Shannon K, Phillips I. 1994. Effect of hyperproduction of TEM-1 beta-lactamase on in vitro susceptibility of Escherichia coli to beta-lactam antibiotics. Antimicrob. Agents Chemother. 38:494-498. doi:10.1128/AAC.38.3.494. (Pubitemid 24072237)